4//SEC Filing
Islam Khalid 4
Accession 0001567619-22-008012
CIK 0001533743other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:57 PM ET
Size
5.7 KB
Accession
0001567619-22-008012
Insider Transaction Report
Form 4
Islam Khalid
Director
Transactions
- Award
Common Stock
2022-03-31+4,392→ 72,486 total
Holdings
- 120,909(indirect: by Elion Oncology, Inc.)
Common Stock
Footnotes (2)
- [F1]Vesting of time-based restricted shares.
- [F2]Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in a transaction exempt from Section 16 reporting pursuant to Rule 16a-13.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001701858
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:57 PM ET
- Size
- 5.7 KB